CARMUSTINE FOR INJECTION USP
Google image searchProduct monograph
Active ingredient
carmustine, 100 MG/VIAL
DIN: 02531879
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: STERIMAX INC
Date: 18-MAY-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01A — ALKYLATING AGENTS (ATC, ATC/DDD)
- L01AD — Nitrosoureas (ATC, ATC/DDD)
- L01AD01 — CARMUSTINE (ATC/DDD)
Reference brand drug: Bicnu
Pharmaceutical standard: USP
